<DOC>
	<DOCNO>NCT00314808</DOCNO>
	<brief_summary>This study seek define tolerability safety associate administration Dronabinol treatment adult nausea , vomit appetite loss patient primary glioma undergo chemotherapy treatment . The study also describe effect Dronabinol quality life term nausea , vomit anorexia patient group .</brief_summary>
	<brief_title>A Pilot Study Dronabinol Adult Patients With Primary Gliomas</brief_title>
	<detailed_description>Symptoms identify impact quality life include nausea vomiting , appetite change , pain , fatigue , mobility , insomnia , mood , bowel pattern , concentration appearance ( Donaldson Fields , 1998 ) . There little information publish impact symptom glioblastoma multiforme ( GBM ) population . More specifically , date , investigation demonstrate efficacy intervention improve appetite , decrease nausea vomit patient GBM . This need serve basis current propose investigation utilize Dronabinol , cannabinoid know decrease incidence nausea vomiting , well control appetite change terminally ill patient receive chemotherapy . In addition , publish research use Dronabinol dose limited toxicity brain tumor population . In study , patient receive daily Dronabinol therapy chemotherapy cycle . Patients complete daily appetite nausea/vomiting log , well receive telephone follow-up research coordinator assess impact treatment . This assess two consecutive cycle chemotherapy .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Patients histologically confirm diagnosis primary malignant brain tumor ( grade 3 4 ) Karnofsky great equal 80 % Life expectancy great equal 6 month Patients must undergo one follow chemotherapy administration : Temozolomide ; Lomustine ( CCNU ) Irinotecan Camptosar ( CPT11 ) Patients must give write informed consent Patients must aspartate aminotransferase ( AST ) , alanine transaminase ( ALT ) , total serum bilirubin , alkaline phosphatase less 2 time upper limit normal laboratory value , perform within 14 day prior initiation study For woman , negative risk pregnancy standard chemotherapy screening procedure inclusive pregnancy test , menopause surgical procedure Patient must social support caregiver daily monitoring side effect Premorbid central nervous system ( CNS ) diagnosis ( cerebral vascular accident ( CVA ) , close head injury ( CHI ) , multiple sclerosis ( MS ) Patients global aphesis limit informed consent process Patients unmanaged psychiatric disease Patients history drug addiction recent illicit drug usage within last 3 month Patients hypersensitivity dronabinol , marijuana sesame seed oil Patients must take concomitant med contraindicate Dronabinol ( include anxiolytic , sedative , hypnotic , barbiturate , general anesthetic , monoamine oxidase inhibitor [ MAOIs ] , opiate agonist , phenothiazine , sedate H1 blocker , skeletal muscle relaxant sympathomimetics ) Patients hepatic enzyme elevation great two time upper limit normal laboratory value AST , ALT , total serum bilirubin alkaline phosphatase Pregnant breastfeed woman Women childbearing potential use effective method contraception ( oral contraceptive , female and/or male barrier device , spermicidal agent , surgical procedure inhibit contraception ) Patients live alone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>primary glioma</keyword>
	<keyword>brain tumor</keyword>
	<keyword>vomit</keyword>
	<keyword>appetite suppression</keyword>
	<keyword>appetite</keyword>
</DOC>